Ledger.Open graph →
SEC Form D · filed April 29, 2022

Kelonia Therapeutics, Inc

Offering
$50.3M
Sold
$50.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Michael Fischbach · Cambridge, MADirectorBob More · San Mateo, CADirectorKevin Friedman · Cambridge, MAExec · DirectorMichael Birnbaum · Cambridge, MADirectorBryan Roberts · Fort Washington, PADirectorBob More · CAMBRIDGE, MADirectorKevin Friedman · Cambridge, MAExec · DirectorMichael Fischbach · Cambridge, MADirectorMichael Birnbaum · Cambridge, MADirectorBryan Roberts · Hampton, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗